186 related articles for article (PubMed ID: 7714761)
1. Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery.
MacAllister RJ; Calver AL; Riezebos J; Collier J; Vallance P
J Pharmacol Exp Ther; 1995 Apr; 273(1):154-60. PubMed ID: 7714761
[TBL] [Abstract][Full Text] [Related]
2. Effects of nitrovasodilators on the human fetal-placental circulation in vitro.
Zhang XQ; Kwek K; Read MA; Donoghue JF; Walters WA
Placenta; 2001 Apr; 22(4):337-46. PubMed ID: 11286570
[TBL] [Abstract][Full Text] [Related]
3. S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery.
Sogo N; Campanella C; Webb DJ; Megson IL
Br J Pharmacol; 2000 Nov; 131(6):1236-44. PubMed ID: 11082133
[TBL] [Abstract][Full Text] [Related]
4. Determinants of the response of human blood vessels to nitric oxide donors in vivo.
Barba G; Mullen MJ; Donald A; MacAllister RJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1662-8. PubMed ID: 10336566
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
Marks GS; McLaughlin BE; Jimmo SL; Poklewska-Koziell M; Brien JF; Nakatsu K
Drug Metab Dispos; 1995 Nov; 23(11):1248-52. PubMed ID: 8591726
[TBL] [Abstract][Full Text] [Related]
6. Relaxations to SIN-1, nitric oxide, and sodium nitroprusside in canine arteries and veins.
Miller VM; Vanhoutte PM
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S67-71. PubMed ID: 2484703
[TBL] [Abstract][Full Text] [Related]
7. Interaction between endothelium-derived nitric oxide and SIN-1 in human and porcine blood vessels.
Lüscher TF; Richard V; Yang ZH
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S76-80. PubMed ID: 2484705
[TBL] [Abstract][Full Text] [Related]
8. In vitro vasorelaxant and in vivo cardiovascular effects of S-nitrosothiols: comparison to and cross tolerance with standard nitrovasodilators.
Smith MP; Humphrey SJ; Kerr SW; Mathews WR
Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):323-35. PubMed ID: 7934311
[TBL] [Abstract][Full Text] [Related]
9. Effects of the flavoprotein inhibitor, diphenyleneiodonium sulfate, on ex vivo organic nitrate tolerance in the rat.
Ratz JD; McGuire JJ; Anderson DJ; Bennett BM
J Pharmacol Exp Ther; 2000 May; 293(2):569-77. PubMed ID: 10773030
[TBL] [Abstract][Full Text] [Related]
10. A novel S-nitrosothiol (RIG200) causes prolonged relaxation in dorsal hand veins with damaged endothelium.
Sogo N; Wilkinson IB; MacCallum H; Khan SQ; Strachan FE; Newby DE; Megson IL; Webb DJ
Clin Pharmacol Ther; 2000 Jul; 68(1):75-81. PubMed ID: 10945318
[TBL] [Abstract][Full Text] [Related]
11. Effects of glyceryl trinitrate, nitroprusside and nitric oxide on arterial, venous and capillary functions in cat skeletal muscle in vivo.
Ekelund U
Acta Physiol Scand; 1994 Sep; 152(1):93-105. PubMed ID: 7810336
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
13. Radiation sensitisation by nitric oxide releasing agents.
Mitchell JB; Cook JA; Krishna MC; DeGraff W; Gamson J; Fisher J; Christodoulou D; Wink DA
Br J Cancer Suppl; 1996 Jul; 27():S181-4. PubMed ID: 8763876
[TBL] [Abstract][Full Text] [Related]
14. Lack of cross-tolerance to short-term linsidomine in forearm resistance vessels and dorsal hand veins in subjects with nitroglycerin tolerance.
Sütsch G; Kim JH; Bracht C; Kiowski W
Clin Pharmacol Ther; 1997 Nov; 62(5):538-45. PubMed ID: 9390110
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide inhibits falcipain, the Plasmodium falciparum trophozoite cysteine protease.
Venturini G; Colasanti M; Salvati L; Gradoni L; Ascenzi P
Biochem Biophys Res Commun; 2000 Jan; 267(1):190-3. PubMed ID: 10623597
[TBL] [Abstract][Full Text] [Related]
16. Vasodilator effect and tolerance induced by the nitrocompound SIN-1 in rabbit femoral artery.
Govantes C; Rodríguez-Martínez MA; Marín J
Methods Find Exp Clin Pharmacol; 1996; 18(6):387-95. PubMed ID: 8892268
[TBL] [Abstract][Full Text] [Related]
17. Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S-nitroso-N-acetylpenicillamine (SNAP) in vivo.
Ng SS; Pang CC
Br J Pharmacol; 1998 Nov; 125(6):1247-51. PubMed ID: 9863653
[TBL] [Abstract][Full Text] [Related]
18. Generation of nitric oxide from organic nitrovasodilators during passage through the coronary vascular bed and its role in coronary vasodilation and nitrate tolerance.
Schrör K; Woditsch I; Förster S
Blood Vessels; 1991; 28(1-3):62-6. PubMed ID: 1900446
[TBL] [Abstract][Full Text] [Related]
19. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
Henry PJ; Horowitz JD; Louis WJ
J Pharmacol Exp Ther; 1989 Feb; 248(2):762-8. PubMed ID: 2563771
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the action of nitric oxide prodrugs by pyocyanin: mechanistic studies.
Hussain AS; Bozinovski J; Maurice DH; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 1997 May; 75(5):398-406. PubMed ID: 9250373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
